References

Allen, D.L., E.R. Bandstra, B.C. Harrison, S. Thorng and L.S. Stodieck et al., 2009. Effects of spaceflight on murine skeletal muscle gene expression. J. Applied Physiol., 106: 582-595.
CrossRef  |  Direct Link  |  

Andersen, D.C. and D.E. Reilly, 2004. Production technologies for monoclonal antibodies and their fragments. Curr. Opin. Biotechnol., 15: 456-462.
CrossRef  |  PubMed  |  Direct Link  |  

Arbabi-Ghahroudi, M., J. Tanha and R. MacKenzie, 2005. Prokaryotic expression of antibodies. Cancer Metastasis Rev., 24: 501-519.
CrossRef  |  PubMed  |  Direct Link  |  

Bartoli M., J. Poupiot, A. Vulin, F. Fougerousse and L. Arandel et al., 2007. AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not α-sarcoglycan deficiency. Gene Ther., 14: 733-740.
CrossRef  |  Direct Link  |  

Batra, S.K., M. Jain, U.A. Wittel, S.C. Chauhan and D. Colcher, 2002. Pharmacokinetics and biodistribution of genetically engineered antibodies. Curr. Opin. Biotechnol., 13: 603-608.
CrossRef  |  PubMed  |  Direct Link  |  

Hamrick, M.W., P. Arounleut, E. Kellum, M. Cain, D. Immel and L.F. Liang, 2010. Recombinant myostatin (GDF-8) propeptide enhances the repair and regeneration of both muscle and bone in a model of deep penetrant musculoskeletal injury. J. Trauma, 69: 579-583.
CrossRef  |  PubMed  |  

Han, H.Q. and W.E. Mitch, 2011. Targeting the myostatin signaling pathway to treat muscle wasting diseases. Curr. Opin. Support Palliative Care, 5: 334-341.
CrossRef  |  PubMed  |  Direct Link  |  

Lee, S.J., 2004. Regulation of muscle mass by myostatin. Annu. Rev. Cell Dev. Biol., 20: 61-86.
CrossRef  |  PubMed  |  Direct Link  |  

Ma, X.Y., Y.C. Cao, D.M. Shu and Y.Z. Bi, 2004. Cloning, expression and animal immunization experiments of myostatin. Sci. China Ser. C: Life Sci., 34: 522-526.

McCroskery, S., M. Thomas, L. Maxwell, M. Sharma and R. Kambadur, 2003. Myostatin negatively regulates satellite cell activation and self-renewal. J. Cell Biol., 162: 1135-1147.
CrossRef  |  Direct Link  |  

McFarlane, C., G.Z. Hui, W.Z. Amanda, H.Y. Lau and S. Lokireddy et al., 2011. Human myostatin negatively regulates human myoblast growth and differentiation. Am. J. Physiol.-Cell Physiol., 301: C195-C203.
CrossRef  |  PubMed  |  

McPherron, A.C., A.M. Lawler and S.J. Lee, 1997. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature, 387: 83-90.
CrossRef  |  PubMed  |  Direct Link  |  

Proba, K. and D. Riesenberg, 1996. Producing Antibodies in Escherichia coli: From PCR to Fermentation. In: Antibody Engineering: A Practical Approach, McCafferty, J., H.R. Hoogenboom and D.J. Chiswell (Eds.). IRL Press, Oxford, UK., ISBN-13: 9780199635924, pp: 203-252.

Reisz-Porszasz, S., S. Bhasin, J.N. Artaza, R. Shen and I. Sinha-Hikim et al., 2003. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am. J. Physiol.-Endocrinol. Metab., 285: E876-E888.
PubMed  |  Direct Link  |  

Rodriguez-Carmona, E., O. Cano-Garrido, M. Dragosits, M. Maurer and A. Mader et al., 2012. Recombinant Fab expression and secretion in Escherichia coli continuous culture at medium cell densities: Influence of temperature. Process Biochem., 47: 446-452.
CrossRef  |  Direct Link  |  

Rothlisberger, D., A. Honegger and A. Pluckthun, 2005. Domain interactions in the Fab fragment: A comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. J. Mol. Biol., 347: 773-789.
CrossRef  |  PubMed  |  Direct Link  |  

Ruan, G.P., L. Ma, X.W. He, M.J. Meng and Y. Zhu et al., 2005. Efficient production, purification and application of egg yolk antibodies against human HLA-A*0201 heavy chain and light chain (β2m). Protein Exp. Purif., 44: 45-51.
CrossRef  |  

Sartorelli, V. and M. Fulco, 2004. Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy. Sci. STKE. 10.1126/stke.2442004re11

Shortreed, K., A. Johnston and T.J. Hawke, 2008. Satellite Cells and Muscle Repair. In: Skeletal Muscle Damage and Repair, Tiidus, P.M. (Ed.). Chapter 6, Human Kinetics, Champaign, IL., USA., ISBN-13: 9780736058674, pp: 77-88.

Sumner, C.J., C.D. Wee, L.C. Warsing, D.W. Choe, A.S. Ng, C. Lutz and K.R. Wagner, 2009. Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice. Hum. Mol. Genet., 18: 3145-3152.
CrossRef  |  Direct Link  |  

Wagner, K.R., 2005. Muscle regeneration through myostatin inhibition. Curr. Opin. Rheumatol., 17: 720-724.
PubMed  |  

Wehling, M., B. Cai and J.G. Tidball, 2000. Modulation of myostatin expression during modified muscle use. FASEB J., 14: 103-110.
Direct Link  |  

Welle, S., K. Bhatt and C.A. Pinkert, 2006. Myofibrillar protein synthesis in myostatin-deficient mice. Am. J. Physiol.-Endocrinol. Metab., 290: E409-E415.
CrossRef  |  Direct Link  |  

Whittemore, L.A., K. Song, X. Li, J. Aghajanian adn M. Davies et al., 2003. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem. Biophys. Res. Commun., 300: 965-971.
CrossRef  |  

Winter, G. and C. Milstein, 1991. Man-made antibodies. Nature, 349: 293-299.
CrossRef  |  PubMed  |  Direct Link  |  

Wlad, H., A. Ballagi, L. Bouakaz, Z. Gu and J.C. Janson, 2001. Rapid two-step purification of a recombinant mouse Fab fragment expressed in Escherichia coli. Protein Expression Purif., 22: 325-329.
CrossRef  |  Direct Link  |  

Xue, M., Y. Guo, Q. Yan, D. Qin and C. Lu, 2013. Preparation and application of polyclonal antibodiesagainst KSHV v-cyclin. J. Biomed. Res., 27: 421-429.
CrossRef  |  PubMed  |  

Yang, Y., B. Wang, D. Yang, M. Lu and Y. Xu, 2012. Prokaryotic expression of Woodchuck Cytotoxic T Lymphocyte Antigen 4 (wCTLA-4) and preparation of polyclonal antibody to wCTLA-4. Protein Expression Purif., 81: 181-185.
CrossRef  |  Direct Link  |  

Zeng, Y., X. Zhang, Z. Huang, L. Cheng and S. Yao et al., 2007. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: Role of JAK/STAT signaling. J. Virol., 81: 2401-2417.
CrossRef  |  PubMed  |  Direct Link  |  

Zhang, L., V. Rajan, E. Lin, Z. Hu, H.Q. Han et al., 2011. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J., 25: 1653-1663.
CrossRef  |  Direct Link  |  

Zimmers, T.A., M.V. Davies, L.G. Koniaris, P. Haynes and A.F. Esquela et al., 2002. Induction of cachexia in mice by systemically administered myostatin. Science, 296: 1486-1488.
CrossRef  |